ロード中...
Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials
In phase III clinical trials, some adverse events may not be rare or unexpected and can be considered as a primary measure for safety, particularly in trials of life-threatening conditions, such as stroke or traumatic brain injury. In some clinical areas, efficacy endpoints may be highly correlated...
保存先:
| 出版年: | Pharm Stat |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294559/ https://ncbi.nlm.nih.gov/pubmed/22589042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1520 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|